when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
drugs
ONTRUZANT

drug

ONTRUZANT

Marketedupdated 3mo ago

by Samsung Bioepis Co Ltd

Approved

community read0 votes

🐶 often sniffed alongside

top 4

tagApproval20 co-mentions · 5 sources
drugtrastuzumab biosimilar10 co-mentions · 5 sources
companySamsung Bioepis Co Ltd10 co-mentions · 5 sources
drugtrastuzumab10 co-mentions · 5 sources

all catalysts(5)

approval · 5

ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval

ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval

ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval

ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval

ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval

News(0)

no news has mentioned this drug yet

brand

ONTRUZANT

generic

TRASTUZUMAB-DTTB

phase

marketed

Data sources

openFDA · ClinicalTrials.gov

last refreshed 38m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?